The type III secretion system functions as an active interface between EHEC and intestinal epithelial cells. It delivers bacterial effector proteins directly into those host cells, changing the host-microbe interaction from surface contact to intimate attachment. In experimental analysis, detecting this secretion-dependent step helps connect bacterial virulence activity with the establishment of colonization.
Attaching-and-effacing lesions matter because they remove or disrupt the epithelial microvilli at sites of bacterial contact. Microvilli are part of the intestinal cell surface, so their alteration provides a visible cellular outcome of colonization rather than merely evidence that bacteria are present. This lesion pattern helps researchers assess how EHEC attachment changes intestinal epithelial structure.
Shiga toxin production adds a tissue-damaging dimension to colonization. The toxin is not described as the attachment mechanism itself; instead, some EHEC strains produce it after or alongside the colonization process, and its effects can contribute to severe disease, including hemolytic uremic syndrome. Separating these roles clarifies how local adherence and toxin-mediated injury relate.
Not every EHEC strain has the same disease potential because Shiga toxin production occurs in some strains. Therefore, analysis should distinguish shared colonization-associated events from strain-dependent toxin effects. That comparison can help explain why intestinal attachment may be accompanied by different levels or forms of host-tissue damage, even when bacteria establish contact with the intestinal lining.
A useful biological sequence follows bacterial contact with the intestinal lining, type III secretion of effector proteins, intimate attachment, and development of attaching-and-effacing lesions. The analysis can then ask whether the strain produces Shiga toxin and relate these findings to epithelial disruption, bloody diarrhea, or hemolytic uremic syndrome. This sequence links mechanism to outcome.
Informative outcomes include evidence of effector delivery into epithelial cells, intimate bacterial attachment, microvillus disruption, and the presence or absence of Shiga toxin production. Together, these observations distinguish colonization behavior from tissue-damaging potential. They also provide biological context for interpreting how a strain may contribute to symptoms or more serious disease.
Mechanistic findings can identify stages of infection relevant to targeted anti-infective strategies, while toxin- and lesion-associated observations can improve interpretation of disease processes. Because colonization connects bacterial virulence factors with altered intestinal function and clinical outcomes, this research can also inform diagnostic investigations and prevention efforts without treating attachment and toxin activity as identical events.